# Reprise Biomedical, Inc. – FDA Inspection, Nov 20, 2025

Source: https://www.keypedia.com/records/fda_inspections/reprise-biomedical-inc/1b63b727-dbf3-4338-96df-963436576142
Source feed: FDA_Inspections

> FDA inspection 1292234 of Reprise Biomedical, Inc., November 20, 2025. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 820. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1292234
- Company Name: Reprise Biomedical, Inc.
- Inspection Date: 2025-11-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: Minneapolis District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1146260 - 2021-07-08
- FDA Inspection 1085602 - 2019-04-02
- [FDA Inspection 943066 - 2015-09-18](https://www.keypedia.com/records/fda_inspections/reprise-biomedical-inc/c780991b-671a-4042-8667-025451991887)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/tyler-r-courtney/08ea96c4-cd5a-4793-b7e4-fb2b9ee2b9ef)

Company: https://www.keypedia.com/companies/reprise-biomedical-inc/6eef21a0-954c-42b0-ac0a-f7bda7b31f0f

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
